[go: up one dir, main page]

ES2161615B1 - Composiciones de heparinas de muy bajo peso molecular. - Google Patents

Composiciones de heparinas de muy bajo peso molecular.

Info

Publication number
ES2161615B1
ES2161615B1 ES009901671A ES9901671A ES2161615B1 ES 2161615 B1 ES2161615 B1 ES 2161615B1 ES 009901671 A ES009901671 A ES 009901671A ES 9901671 A ES9901671 A ES 9901671A ES 2161615 B1 ES2161615 B1 ES 2161615B1
Authority
ES
Spain
Prior art keywords
compositions
heparins
molecular weight
low molecular
so3na
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009901671A
Other languages
English (en)
Other versions
ES2161615A1 (es
Inventor
Jean Mardiguian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Farmaceuticos Rovi SA
Original Assignee
Laboratorios Farmaceuticos Rovi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009901671A priority Critical patent/ES2161615B1/es
Application filed by Laboratorios Farmaceuticos Rovi SA filed Critical Laboratorios Farmaceuticos Rovi SA
Priority to ES99500184T priority patent/ES2244165T3/es
Priority to DK99500184T priority patent/DK1070503T3/da
Priority to PT99500184T priority patent/PT1070503E/pt
Priority to EP99500184A priority patent/EP1070503B8/en
Priority to AT99500184T priority patent/ATE309693T1/de
Priority to DE69925821T priority patent/DE69925821T2/de
Priority to BR9905820-0A priority patent/BR9905820A/pt
Priority to US09/433,409 priority patent/US6384021B1/en
Priority to JP2000078984A priority patent/JP4897991B2/ja
Publication of ES2161615A1 publication Critical patent/ES2161615A1/es
Application granted granted Critical
Publication of ES2161615B1 publication Critical patent/ES2161615B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Composiciones de heparinas de muy bajo peso molecular, con la fórmula I en la cual, n puede variar entre 1 y 12; R{sub,1} = H ó SO{sub,3}Na; R{sub,2}= SO{sub,3}Na ó COCH{sub,3}. Dichas composiciones de heparina están compuestas de mezclas de oligosacáridos o fragmentos de heparina y están caracterizadas por tener actividad anti Xa y actividad anti factor IIa y porque son utilizables como medicamentos antitrombóticos.
ES009901671A 1999-07-23 1999-07-23 Composiciones de heparinas de muy bajo peso molecular. Expired - Fee Related ES2161615B1 (es)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ES009901671A ES2161615B1 (es) 1999-07-23 1999-07-23 Composiciones de heparinas de muy bajo peso molecular.
DK99500184T DK1070503T3 (da) 1999-07-23 1999-10-13 Sammensætninger indeholdende heparin med lav molekylvægt
PT99500184T PT1070503E (pt) 1999-07-23 1999-10-13 Composicoes compreendendo heparina de peso molecular muito reduzido
EP99500184A EP1070503B8 (en) 1999-07-23 1999-10-13 Compositions comprising low molecular weight Heparin
AT99500184T ATE309693T1 (de) 1999-07-23 1999-10-13 Zusammensetzungen enthaltend heparin mit niedrigem molekülargewicht
DE69925821T DE69925821T2 (de) 1999-07-23 1999-10-13 Zusammensetzungen enthaltend Heparin mit niedrigem Molekülargewicht
ES99500184T ES2244165T3 (es) 1999-07-23 1999-10-13 Composiciones que contienen heparina de bajo peso molecular.
BR9905820-0A BR9905820A (pt) 1999-07-23 1999-10-28 Composições de heparinas de peso molecular muito baixo
US09/433,409 US6384021B1 (en) 1999-07-23 1999-11-03 Heparin compositions of very low molecular weight
JP2000078984A JP4897991B2 (ja) 1999-07-23 2000-03-21 超低分子量ヘパリン組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901671A ES2161615B1 (es) 1999-07-23 1999-07-23 Composiciones de heparinas de muy bajo peso molecular.

Publications (2)

Publication Number Publication Date
ES2161615A1 ES2161615A1 (es) 2001-12-01
ES2161615B1 true ES2161615B1 (es) 2003-03-16

Family

ID=8309360

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009901671A Expired - Fee Related ES2161615B1 (es) 1999-07-23 1999-07-23 Composiciones de heparinas de muy bajo peso molecular.
ES99500184T Expired - Lifetime ES2244165T3 (es) 1999-07-23 1999-10-13 Composiciones que contienen heparina de bajo peso molecular.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99500184T Expired - Lifetime ES2244165T3 (es) 1999-07-23 1999-10-13 Composiciones que contienen heparina de bajo peso molecular.

Country Status (8)

Country Link
US (1) US6384021B1 (es)
EP (1) EP1070503B8 (es)
AT (1) ATE309693T1 (es)
BR (1) BR9905820A (es)
DE (1) DE69925821T2 (es)
DK (1) DK1070503T3 (es)
ES (2) ES2161615B1 (es)
PT (1) PT1070503E (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7575886B2 (en) * 2002-03-11 2009-08-18 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
AR041555A1 (es) 2002-10-10 2005-05-18 Aventis Pharma Sa Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2845686B1 (fr) 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
US20060183712A1 (en) * 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2340902B1 (es) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
CN101711771B (zh) * 2008-10-07 2015-12-09 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制法和药物组合物
CN102791742B (zh) * 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
WO2012072799A1 (en) * 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102816255B (zh) * 2011-06-10 2015-11-25 王芃 一种超低分子肝素钠的制备方法
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
US20160331775A1 (en) * 2015-05-14 2016-11-17 The Regents Of The University Of Michigan E-selectin inhibition works in combination with low-molecular weight heparin to decrease venous thrombosis and bleeding risk
JP7550787B2 (ja) 2019-04-26 2024-09-13 ラボラトリオス ファーマシューティコス ロヴィ エス．エー． タンジェンシャルフロー濾過により低分子量ヘパリンを得る方法
ES2847281A1 (es) * 2020-01-31 2021-08-02 Farm Rovi Lab Sa Heparinas de bajo y muy bajo peso molecular para el tratamiento de trombosis venosa profunda
CN114072430B (zh) * 2020-04-27 2023-07-28 罗威制药股份有限公司 低分子量肝素获取程序以及由此获得的低分子量肝素
CN113384758B (zh) * 2021-06-18 2022-10-04 海思盖德(苏州)生物医学科技有限公司 抗凝血涂层组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548672A1 (fr) * 1983-07-04 1985-01-11 Pharmuka Lab Oligosaccharides sulfates et leur utilisation comme medicaments
ES2003197A6 (es) * 1987-01-05 1988-10-16 Rovi Lab Farmaceut Sa Procedimiento de despolimerizacion de la heparina para la obtencion de una heparina de bajo peso molecular dotada de actividad antitrombotica
US4981955A (en) * 1988-06-28 1991-01-01 Lopez Lorenzo L Depolymerization method of heparin
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
JP3522775B2 (ja) * 1992-07-03 2004-04-26 生化学工業株式会社 ヘパリン不飽和４糖およびその製造法
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
CA2272317C (en) * 1996-11-27 2001-01-30 Rhone-Poulenc Rorer Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
AU7753898A (en) * 1997-06-06 1998-12-21 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors

Also Published As

Publication number Publication date
ATE309693T1 (de) 2005-07-15
ES2244165T3 (es) 2005-12-01
DE69925821T2 (de) 2006-05-18
DE69925821D1 (de) 2005-07-21
ES2161615A1 (es) 2001-12-01
US6384021B1 (en) 2002-05-07
EP1070503B8 (en) 2005-09-14
DK1070503T3 (da) 2005-12-05
EP1070503B1 (en) 2005-06-15
BR9905820A (pt) 2001-03-13
PT1070503E (pt) 2005-10-31
EP1070503A1 (en) 2001-01-24

Similar Documents

Publication Publication Date Title
ES2161615B1 (es) Composiciones de heparinas de muy bajo peso molecular.
CY1108001T1 (el) Παραγωγα μερικα αποθειωμενων γλυκοζαμινογλυκανων προικισμενα με αντι-αγγειογονο δραστηριοτητα και χωρις αντιπηκτικη επιδραση
KR100479182B1 (ko) 폴리히드록시알카노에이트의 제조에 이용되는 미생물
BRPI0311716A2 (pt) composição que contém um polímero catiônico com uma alta densidade de carga e um agente condicionador
DK0842934T3 (da) 5-HT1F agonister
NO903089D0 (no) Polymere basisblandinger med strukturendret stivelse.
DK1000033T3 (da) Heterocykliske derivater, som inhiberer Faktor Xa
IT1230968B (it) Composizioni polimeriche autoestinguenti.
ITMI912216A1 (it) Pentaeritril fosfonati e loro utilizzo in composizioni polimeriche termoplastiche autoestinguenti
FI931740A0 (fi) Semisyntetiska glukosaminoglykaner innehaollande a-l-galakturonsyra somaer substituerad i 3-staellning med nukleofila radikaler
BR0207646A (pt) Composição estabilizadora para polìmeros halogenados, uso da mesma e polìmeros que compreendem tais composições
DE69923444D1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
DE60208211D1 (de) Polycarbonatharzzusammensetzungen und daraus hergestellte artikel
IT1246275B (it) Composti ammelinici e loro impiego in composizioni polimeriche autoestinguenti
ID25478A (id) Agonis 5-ht1f
NO996212L (no) Polymerblanding med høy transparens
BR9909461A (pt) Dibenzonaftironas e o uso das mesmas para colorir ou pigmentar material orgânico de alto peso molecular
ATE552004T1 (de) Oral verabreichbare heparinderivate

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20011201

Kind code of ref document: A1

Effective date: 20011201

FG2A Definitive protection

Ref document number: 2161615B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100315